PDGFB in Breast Cancer Initiation,Progression, and Metastasis - A cross journal collection
Submission deadline: 31 May 2022
The family of platelet derived growth factors (PDGF) encompasses proangiogenic factors, which have been associated with progression of malignancies, including breast cancer. Recent studies indicated that expression of PDGFB is an important prognostic factor in certain breast cancer types, and that combination of PDGFR inhibitors with targeted therapy could significantly increase survival. In this cross-journal collection, we welcome a wide range of articles on the role of PDGFB in mammary gland development, breast cancer initiation, progression, and metastasis, including primary research articles, reviews, and perspectives.
To express your interest to contribute, please contact the Editor-in-Chief of the respective journal:
Breast Cancer Research: Lewis A. Chodosh (firstname.lastname@example.org)
Journal of Mammary Gland Biology and Neoplasia: Zuzana Koledova (email@example.com)
Breast Cancer Research & Treatment: William J. Gradishar (firstname.lastname@example.org)